Akso Health Group (NASDAQ:AHG - Get Free Report) was upgraded by analysts at Wall Street Zen to a "sell" rating in a report issued on Saturday.
Separately, Weiss Ratings reissued a "sell (d-)" rating on shares of Akso Health Group in a research report on Monday, April 20th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of "Sell".
Get Our Latest Stock Analysis on Akso Health Group
Akso Health Group Price Performance
NASDAQ:AHG opened at $2.14 on Friday. Akso Health Group has a 12-month low of $1.07 and a 12-month high of $2.50. The firm has a 50-day moving average price of $2.04 and a 200 day moving average price of $1.69.
Institutional Trading of Akso Health Group
A hedge fund recently raised its stake in Akso Health Group stock. SmartHarvest Portfolios LLC raised its position in shares of Akso Health Group Sponsored ADR (NASDAQ:AHG - Free Report) by 111.5% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,429 shares of the company's stock after buying an additional 18,681 shares during the period. SmartHarvest Portfolios LLC's holdings in Akso Health Group were worth $81,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 1.21% of the company's stock.
About Akso Health Group
(
Get Free Report)
Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc and changed its name to Akso Health Group in December 2021.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Akso Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Akso Health Group wasn't on the list.
While Akso Health Group currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.